Diamond Biotechnology Co., Ltd - Laporan Laba Rugi (TTM)

Diamond Biotechnology Co., Ltd
TW ˙ TPEX
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Diamond Biotechnology Co., Ltd menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 295 306 309 311 353 395 415 435 435 435 487 538 577 616 662 708 738 768 733 698
Change (%) 3.88 0.76 0.75 13.53 11.92 4.98 4.74 0.03 0.03 11.89 10.63 7.23 6.74 7.42 6.91 4.29 4.11 -4.56 -4.78
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 163 178 179 180 194 207 217 227 239 251 279 307 317 327 351 375 408 438 426 414
Change (%) 9.02 0.70 0.69 7.45 6.93 4.68 4.47 5.25 4.99 11.25 10.11 3.20 3.10 7.43 6.91 8.69 7.35 -2.69 -2.77
% of Revenue 55.35 58.08 58.05 58.01 54.90 52.46 52.31 52.18 54.90 57.61 57.28 57.01 54.87 53.00 53.00 53.00 55.24 56.95 58.07 59.30
Gross Operating Profit 132 128 130 131 159 188 198 208 196 184 208 231 260 290 311 333 330 331 307 284
Change (%) -2.49 0.85 0.84 21.93 17.98 5.31 5.04 -5.65 -5.99 12.77 11.32 12.58 11.17 7.41 6.90 -0.67 0.12 -7.04 -7.58
% of Revenue 44.65 41.92 41.95 41.99 45.10 47.54 47.69 47.82 45.10 42.39 42.72 42.99 45.13 47.00 47.00 47.00 44.76 43.05 41.93 40.70
SG&A 102 111 117 123 118 112 107 102 107 112 127 142 169 196 199 202 191 181 186 191
Change (%) 8.16 5.84 5.52 -4.61 -4.84 -4.33 -4.53 4.78 4.56 13.27 11.71 19.18 16.09 1.37 1.35 -5.14 -5.42 2.81 2.74
% of Revenue 34.65 36.08 37.90 39.69 33.35 28.36 25.85 23.56 24.68 25.79 26.11 26.37 29.30 31.87 30.08 28.51 25.93 23.56 25.38 27.39
R&D 3 3 7 12 20 28 29 31 28 26 25 25 27 29 32 35 38 41 42 43
Change (%) 9.84 154.67 60.73 67.95 40.46 5.07 4.83 -7.84 -8.50 -2.28 -2.33 9.25 8.47 9.16 8.39 9.64 8.79 2.37 2.32
% of Revenue 0.89 0.94 2.39 3.81 5.63 7.07 7.07 7.08 6.52 5.96 5.21 4.60 4.69 4.76 4.84 4.91 5.16 5.39 5.78 6.21
OpEx 268 291 304 316 332 347 354 360 374 389 431 474 513 552 582 611 637 660 654 649
Change (%) 8.70 4.18 4.01 5.00 4.76 1.80 1.77 4.00 3.84 10.93 9.85 8.30 7.67 5.37 5.09 4.18 3.60 -0.86 -0.87
% of Revenue 90.89 95.11 98.33 101.51 93.89 87.89 85.23 82.81 86.09 89.37 88.60 87.98 88.86 89.63 87.91 86.42 86.33 85.90 89.23 92.90
Operating Income 27 15 5 -5 22 48 61 75 60 46 55 65 64 64 80 96 101 108 79 50
Change (%) -44.20 -65.68 -191.38 -559.34 121.77 28.00 21.87 -19.06 -23.55 20.00 16.67 -0.62 -0.62 25.18 20.11 4.99 7.36 -27.12 -37.21
% of Revenue 9.11 4.89 1.67 -1.51 6.11 12.11 14.77 17.19 13.91 10.63 11.40 12.02 11.14 10.37 12.09 13.58 13.67 14.10 10.77 7.10
Interest Expense -2 -2 -2 -2 -2 -2 -3 -3 -3 -4 -5 -6 -7 -8 -8 -8 -8 -7 -7 -6
Change (%) 8.21 -3.75 -3.90 -0.44 -0.44 12.30 10.95 16.01 13.80 27.47 21.55 14.90 12.97 4.17 4.00 -4.32 -4.52 -11.55 -13.06
% of Revenue -0.78 -0.81 -0.77 -0.74 -0.65 -0.58 -0.62 -0.65 -0.76 -0.86 -0.98 -1.08 -1.15 -1.22 -1.18 -1.15 -1.06 -0.97 -0.90 -0.82
Net Income 20 11 3 -4 19 42 53 64 48 33 40 46 46 47 56 64 67 73 54 35
Change (%) -44.99 -69.33 -226.03 -540.75 122.69 25.84 20.54 -23.75 -31.14 18.63 15.70 1.00 0.99 18.82 15.84 4.84 8.52 -25.97 -35.09
% of Revenue 6.81 3.61 1.10 -1.37 5.33 10.61 12.72 14.63 11.15 7.68 8.14 8.51 8.02 7.59 8.39 9.09 9.14 9.53 7.39 5.04

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista